{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:35:44Z","timestamp":1786642544747,"version":"build-2736575974"},"reference-count":27,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI162684"],"award-info":[{"award-number":["R01AI162684"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI178367"],"award-info":[{"award-number":["R21AI178367"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"award":["R01AI162684"],"award-info":[{"award-number":["R01AI162684"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R21AI178367"],"award-info":[{"award-number":["R21AI178367"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Inflammasomes are central mediators of innate immune defense but can also drive pathological inflammation and pyroptotic cell death in numerous diseases. While several small-molecule inhibitors have been described, many selectively target individual inflammasomes or act through the adaptor protein ASC, leaving ASC-independent pathways unaffected. We previously identified thiomuscimol as a broad-spectrum inflammasome inhibitor that blocks both ASC-dependent and ASC-independent activation, although the structural basis for this activity remains unclear. Here, we examined the structure\u2013activity relationship of thiomuscimol using related compounds and synthetic analogs. In primary macrophages, inflammasome activation and pyroptosis were assessed by live cell imaging of ASC speck formation, gasdermin D-mediated dye uptake, and cellular ATP levels. Structurally related sulfur-containing molecules, including taurine and isothiazole, failed to inhibit inflammasome activation, indicating that neither the sulfur in an electron-rich environment nor the heterocyclic scaffold confer activity. Replacement of the primary amine with a carbonyl group abolished activity, whereas substitution with a secondary amine preserved inhibitory potency comparable to thiomuscimol. Incorporation of the amine into an annulated piperidine ring reduced potency and revealed sensitivity to the precise positioning of the amine within the ring. Together, these findings identify key structural features required for thiomuscimol-mediated inflammasome inhibition and provide a framework for future studies to define its mechanism of action and guide the development of improved inhibitors.<\/jats:p>","DOI":"10.3390\/ijms27167235","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:01:35Z","timestamp":1786640495000},"page":"7235","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure\u2013Activity Relationship for Inflammasome Inhibition by Thiomuscimol"],"prefix":"10.3390","volume":"27","author":[{"given":"Marisa J.","family":"Anderson","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy P.","family":"Loomis","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas B.","family":"den Hartigh","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Fr\u00f8lund","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100-\u00d8 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-0103","authenticated-orcid":false,"given":"Susan L.","family":"Fink","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1146\/annurev-immunol-101320-011235","article-title":"Innate Sensors Trigger Regulated Cell Death to Combat Intracellular Infection","volume":"40","author":"Nozaki","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41577-024-00995-w","article-title":"Mechanistic insights from inflammasome structures","volume":"24","author":"Fu","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"101803","DOI":"10.1016\/j.smim.2023.101803","article-title":"Pyroptosis and the cellular consequences of gasdermin pores","volume":"69","author":"Huston","year":"2023","journal-title":"Semin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","article-title":"Inflammasome components as new therapeutic targets in inflammatory disease","volume":"25","author":"Coll","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zhu, L., Hu, M., Xu, H., Xu, H., Ren, B., Xu, R., Guo, M., Chen, H., Zhang, D., and Fang, H. (2025). The key players of inflammasomes and pyroptosis in sepsis-induced pathogenesis and organ dysfunction. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1586364"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JIR.S178084","article-title":"Inflammasomes: Pandora\u2019s box for sepsis","volume":"11","author":"Kumar","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41392-024-01958-2","article-title":"Pyroptosis in health and disease: Mechanisms, regulation and clinical perspective","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/13543776.2026.2656161","article-title":"A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)","volume":"36","author":"Namme","year":"2026","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: From signalling mechanisms to therapeutic targets","volume":"23","author":"Lamkanfi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A 360 degrees view of the inflammasome: Mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41419-021-04420-1","article-title":"Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases","volume":"12","author":"Pardo","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chom.2010.11.007","article-title":"Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing","volume":"8","author":"Broz","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1038\/ncomms4209","article-title":"Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation","volume":"5","author":"Gurung","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41420-024-02238-2","article-title":"Broad-spectrum inflammasome inhibition by thiomuscimol","volume":"10","author":"Anderson","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/s42003-023-05354-4","article-title":"Muscimol inhibits plasma membrane rupture and ninjurin-1 oligomerization during pyroptosis","volume":"6","author":"Loomis","year":"2023","journal-title":"Commun. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1523\/JNEUROSCI.3996-07.2008","article-title":"Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus","volume":"28","author":"Jia","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.celrep.2016.06.011","article-title":"A Fluorescent Reporter Mouse for Inflammasome Assembly Demonstrates an Important Role for Cell-Bound and Free ASC Specks during In Vivo Infection","volume":"16","author":"Tzeng","year":"2016","journal-title":"Cell Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-0716-2553-8_15","article-title":"Simultaneous Detection of Inflammasome Activation and Membrane Damage During Pyroptosis","volume":"2543","author":"Fink","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"167246","DOI":"10.1016\/j.jmb.2021.167246","article-title":"Regulation of Lytic and Non-Lytic Functions of Gasdermin Pores","volume":"434","author":"Ruhl","year":"2022","journal-title":"J. Mol. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s15010-022-01904-w","article-title":"DFV890: A new oral NLRP3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function","volume":"51","author":"Madurka","year":"2023","journal-title":"Infection"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","article-title":"Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders","volume":"66","author":"Harrison","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_23","unstructured":"Kazmierski, W.M., Aquino, C.J., Bifulco, N., Boros, E.E., Chauder, B.A., Chong, P.Y., Duan, M., Deanda, F., Koble, C.S., and McLean, E.W. (2004). Piperidine Derivatives as CCR5 Inhibitors. (WO 2004\/054974 A2), Available online: https:\/\/patents.google.com\/patent\/WO2004054974A2\/nl."},{"key":"ref_24","first-page":"447","article-title":"R, Synthesis, GABA agonist activity and effects on GABA and diazepam binding of some N-substituted analogues of GABA","volume":"20","author":"Falch","year":"1985","journal-title":"Eur. J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1016\/j.bmc.2003.09.016","article-title":"Aza-THIP and related analogues of THIP as GABA C antagonists","volume":"11","author":"Krehan","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1021\/jm00360a020","article-title":"4,5,6,7-Tetrahydroisothiazolo [5,4-c]pyridin-3-ol and related analogues of THIP. Synthesis and biological activity","volume":"26","author":"Mikkelsen","year":"1983","journal-title":"J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/jm050987l","article-title":"Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive\/noncompetitive antagonists: Synthesis and pharmacology","volume":"49","author":"Krehan","year":"2006","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7235\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T17:02:42Z","timestamp":1786640562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":27,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167235"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167235","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}